Article No
AMB-5W3TBI-100
MW | 61kDa |
Application | ELISA, FC, ICC |
Article No | AMB-5W3TBI-100 |
Biosite Brand | Biosite mAb |
Country Availability | all |
Clone | 2E2 |
Clone Type | monoclonal |
Conjugation | Unconjugated |
Description | CD19 Primary Antibody |
Supplier | Nordic Biosite |
Entrez Gene ID | 930 |
Format | Ascitic fluid containing 0.03% sodium azide. |
Immunogen | Purified recombinant fragment of human CD19 expressed in E. Coli. |
Isotype | IgG2b |
Notes | The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation. |
Alias Names | B4; MGC12802 |
Previous Article No | AMB-8478 |
Product Type | Antibodies Primary |
Protocol | ELISA: 1/10000; ICC: 1/200 - 1/1000; FCM: 1/200 - 1/400 |
Size | 100µl |
Source / Host | mouse |
Species Reactivity | human |
Storage | 4°C -20°C for long term storage |
Substrate / Buffer | Ascitic fluid containing 0.03% sodium azide. |
Technical Specifications | ELISA: 1/10000; ICC: 1/200 - 1/1000; FCM: 1/200 - 1/400 |
Product Page Updated | 2024-01-25T14:27:22.065Z |